Your Search
- All results
- Pages
- Articles in the press
- Brochures
- Company news
- Educational resources
- News
- Podcasts
- Press releases
- Videos
- Events
Conventional Tablets May No Longer Be the Go-To-Solution
Market study reveals difficulties swallowing tablets wide-spread and opens up new revenue opportunitiesPullach, Germany, September 2, 2014 – Hermes Pharma, the expert in the development and production of user-friendly solid oral dosage forms, today announced the findings of an international survey exploring the nature of difficulties …
HERMES PHARMA Completes Successful Routine FDA Inspection of Production Facility
Inspection Opens Door for HERMES PHARMA to Increase Production of User-friendly Solid Oral Dosage Forms for the USPullach, Germany, June 26, 2013 HERMES PHARMA, a division of HERMES Arzneimittel GmbH and Europe’s largest developer and manufacturer of user-friendly solid oral dosage forms, recently completed a successful …
Swallowing Tablets is a Massive Problem for Growing Numbers of People
User-Friendly Dosage Forms Enable Pharmaceutical Companies to InnovatePullach, Germany, April 24, 2013 While the pharmaceutical industry concentrates on developing new ever more effective compounds, the basic needs of patients go often ignored. Historically, because of low cost, simplicity and public familiarity, oral application became the main …
New Taste-Masking Technologies Facilitate User-Friendly Pharmaceuticals
Odor and taste are key for the acceptance of dosage forms that dissolve in the mouth. Hermes Pharma, INNOJET Herbert Hüttlin, RCPE and Karl Franzens University research new approaches to increase patient compliance and improve production processes.Pullach, Germany, September 6, 2012 – Hermes Pharma, the expert …
Oxford Pharmascience and HERMES PHARMA partner to develop new Ibuprofen product
Heads of Terms signed for a range of OXP zero ibuprofen productsOxford Pharmascience, the specialty pharmaceutical company that uses advanced pharmaceutic technologies to reposition medicines, today announces it has signed a Heads of Terms agreement with HERMES PHARMA to license and develop a range of …